FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3133646944> ?p ?o ?g. }

• W3133646944 abstract "Background: Feline Injection Site-Associated Sarcoma (FISS) is a mesenchymal neoplasia of aggressive behavior that develops in sites where vaccine or drugs were administered. FISS is clinically characterized by the appearance of a solitary firm nodule or a diffuse mass, adhered to tissues, in regions associated to vaccine or drug applications. Despite low prevalence, tumor recurrence rates can reach 80%. FISS present more aggressive histological characteristics when compared to sarcomas not associated to injection sites. The aim of this paper is to contribute towards the understanding of the biological behavior of FISS.Materials, Methods & Results: Sixteen samples of FISS were analyzed. Fibrosarcomas were the most frequent histological subtype (62.5%). Malignant peripheral nerve sheath tumor was diagnosed in 18.75% cases. Ten (62.5%) FISS were classified as grade II; 4/16 (25%) grade I, and 2/16 (12.5%) grade III. Cox-2 overexpression occurred in 3/16 (18.75%) samples, with positive correlation between Cox-2 expression and cellularity (r = 0.696, P = 0.003). Mitotic index lower than 9 events was found in 11/16 (68.7%) samples and between 10 and 19 mitotic events in 5/16 (31.3%) cases. Mean Ki-67 expression was 2.39 ± 2.48%. FISS characterized as fibrosarcomas presented longer overall survival (median 545 days) than other histological subtypes (median 130.5 days) [P = 0.01].Discussion: Patients with FISS generally present with larger nodules than those with sarcomas not associated to injections, suggesting a challenge for pet owners to note subcutaneous tumors in the interscapular region, in addition to the aggressive biological behavior of FISS. The influence of size on prognosis remains controversial. An association between histologic grade and the development of metastasis has been observed, with patients with grade III FISS associated with an increase in the metastatic rate. The present study did not find a correlation between overall survival and histologic grade. A positive correlation between the presence of giant multinucleated cells and tumor grade has been observed.Despite the absence of such correlation in the present study, possibly due to a small sample, a trend for higher frequency of giant cells in advanced histologic grade was observed. Cox-2 expression in 81.75% and overexpression in 18.75% of our samples contrasts with the 64% Cox-2 expression and the absence of Cox-2 expression found by other authors. A positive moderate correlation between cellularity and Cox-2 expression was also observed, while another study did not find a correlation of Cox-2 expression with tumor grade, recurrence rates or overall survival. Cox metabolites such as prostaglandins can enhance cellular proliferation, inhibit apoptosis, induce angiogenesis, alter cellular adherence to facilitate metastatic development and inhibit immune surveillance. In the present study, no correlation was found between Cox-2 and angiogenesis in FISS. Our findings demonstrated low immunolabeling for Ki-67. A previous study analyzed 52 samples of FISS, 51% of them considered grade III, with a mean Ki-67 labeling of 14%. The lower Ki-67 staining in the samples of the present study may be related to the lower number of samples of grade III FISS or to a difference in the studied population. Fibrosarcomas are associated with better prognosis than other histological subtypes. Furthermore, malignant peripheral nerve sheath tumors were diagnosed as a possible histological subtype of FISS." @default.
• W3133646944 created "2021-03-15" @default.
• W3133646944 creator A5006357889 @default.
• W3133646944 creator A5012394669 @default.
• W3133646944 creator A5021459076 @default.
• W3133646944 creator A5024086661 @default.
• W3133646944 creator A5072768878 @default.
• W3133646944 creator A5078268159 @default.
• W3133646944 creator A5084372661 @default.
• W3133646944 date "2021-02-15" @default.
• W3133646944 modified "2023-10-15" @default.
• W3133646944 title "Histomorphological and Immunophenotypic Characterization of Feline Injection Site-Associated Sarcoma" @default.
• W3133646944 cites W2022146972 @default.
• W3133646944 cites W2028307569 @default.
• W3133646944 cites W2046293893 @default.
• W3133646944 cites W2069868741 @default.
• W3133646944 cites W2094269691 @default.
• W3133646944 cites W2108133718 @default.
• W3133646944 cites W2124548256 @default.
• W3133646944 cites W2138894818 @default.
• W3133646944 cites W2152210518 @default.
• W3133646944 cites W2400759110 @default.
• W3133646944 doi "https://doi.org/10.22456/1679-9216.109525" @default.
• W3133646944 hasPublicationYear "2021" @default.
• W3133646944 type Work @default.
• W3133646944 sameAs 3133646944 @default.
• W3133646944 citedByCount "0" @default.
• W3133646944 crossrefType "journal-article" @default.
• W3133646944 hasAuthorship W3133646944A5006357889 @default.
• W3133646944 hasAuthorship W3133646944A5012394669 @default.
• W3133646944 hasAuthorship W3133646944A5021459076 @default.
• W3133646944 hasAuthorship W3133646944A5024086661 @default.
• W3133646944 hasAuthorship W3133646944A5072768878 @default.
• W3133646944 hasAuthorship W3133646944A5078268159 @default.
• W3133646944 hasAuthorship W3133646944A5084372661 @default.
• W3133646944 hasBestOaLocation W31336469441 @default.
• W3133646944 hasConcept C142724271 @default.
• W3133646944 hasConcept C2778256501 @default.
• W3133646944 hasConcept C57742111 @default.
• W3133646944 hasConcept C66640590 @default.
• W3133646944 hasConcept C71924100 @default.
• W3133646944 hasConcept C86803240 @default.
• W3133646944 hasConcept C93304396 @default.
• W3133646944 hasConcept C95444343 @default.
• W3133646944 hasConceptScore W3133646944C142724271 @default.
• W3133646944 hasConceptScore W3133646944C2778256501 @default.
• W3133646944 hasConceptScore W3133646944C57742111 @default.
• W3133646944 hasConceptScore W3133646944C66640590 @default.
• W3133646944 hasConceptScore W3133646944C71924100 @default.
• W3133646944 hasConceptScore W3133646944C86803240 @default.
• W3133646944 hasConceptScore W3133646944C93304396 @default.
• W3133646944 hasConceptScore W3133646944C95444343 @default.
• W3133646944 hasLocation W31336469441 @default.
• W3133646944 hasOpenAccess W3133646944 @default.
• W3133646944 hasPrimaryLocation W31336469441 @default.
• W3133646944 hasRelatedWork W14890353 @default.
• W3133646944 hasRelatedWork W14974779 @default.
• W3133646944 hasRelatedWork W1612859 @default.
• W3133646944 hasRelatedWork W17632607 @default.
• W3133646944 hasRelatedWork W18478890 @default.
• W3133646944 hasRelatedWork W21886592 @default.
• W3133646944 hasRelatedWork W2686662 @default.
• W3133646944 hasRelatedWork W4255617 @default.
• W3133646944 hasRelatedWork W800868 @default.
• W3133646944 hasRelatedWork W10184286 @default.
• W3133646944 isParatext "false" @default.
• W3133646944 isRetracted "false" @default.
• W3133646944 magId "3133646944" @default.
• W3133646944 workType "article" @default.